Mr Stergis replaces Steve Kanzer who will continue to serve as Pipex’s chairman. Daniel Dorman, a director of the company, has resigned and Charles Bisgaier, Pipex’s president, has resigned from the company to establish a Michigan-based venture capital group focused on the life sciences sector.
Mr Stergis was co-founder of Pipex Therapeutics, the predecessor company, and has been vice chairman of Pipex’s board of directors since March 2007.
Mr Kanzer said: “I feel confident in Nicholas’s operational strengths, business acumen, business development capabilities and look forward to his service as CEO to create substantial value for our shareholders.”